ReCode Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
ReCode Therapeutics, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 5 Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending. The owner is based in Menlo Park, CA.
1140 O'Brien Drive
Menlo Park, CA 94025
Showing of trademarks Trademarks
Trademark Classifications
ReCode Therapeutics, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ReCode Therapeutics, Inc. have?
ReCode Therapeutics, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 pending, 3 abandoned.
What trademark classes does ReCode Therapeutics, Inc. file in?
ReCode Therapeutics, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What is ReCode Therapeutics, Inc.'s trademark registration success rate?
ReCode Therapeutics, Inc. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.